Why Doesn’t Anybody Realize We’re Going Back to the Moon?

Artemis II launched as the first crewed mission to reach lunar orbit in more than 50 years, but the crew will not land and will swing around the moon’s far side before returning. The Space Launch System (SLS) is described as likely the most expensive rocket per launch, taking 11 years to develop versus Saturn V’s 6 years and being single-use/technologically obsolete, creating fiscal risk as future lunar landings depend on Congress and future administrations. The event is highly symbolic and inspiring, but program sustainment and costs, plus geopolitical competition with China, are the primary risks for investors and policymakers.

Analysis

This launch is a political and industrial fulcrum more than a pure technology story: SLS/Orion is a single-use, politically-backed cash pump that props up specific prime contractors for years even while reusable rivals (Starship/Falcon) cannibalize the commercial launch market. Expect multi-year, lumpy revenue streams into Boeing/Lockheed/Northrop through contracted milestones and sustainment work — revenues that are highly correlated with appropriations cycles, not commercial demand curves.

Second-order winners are firms that supply heavy structures, avionics and cryogenic systems (large composite shops, avionics integrators, ground-segment telemetry) where lead times exceed 12–24 months; small regional suppliers and ports on Florida’s Space Coast will see outsized economic multipliers. Conversely, small public pure-play launchers and suppliers that bet on high cadence commercial manifest growth will face margin compression as national prestige programs divert skilled labor and factory slots for guaranteed government work.

Key tail-risks center on political change and mission outcome: a high-profile failure this flight or a White House/Congressional reprioritization within 6–18 months materially increases cancellation risk for follow-on SLS buys and forces primes to transition work to commercial partners. A successful, clean mission however creates immediate political momentum and improves the probability of 12–36 month incremental appropriations, effectively derisking fixed-price contract milestones and option exercises for primes.

The market consensus underprices the durability of pork-barrel aerospace spending: even if SLS is technologically obsolete, sunk-cost dynamics plus local jobs and congressional sponsorship make full program wind-down politically costly. That structural stickiness argues for asymmetric exposure to large defense/aerospace primes rather than to volatile small-cap launchers that will feel the squeeze first.

Key Decisions for Investors

• Long Northrop Grumman (NOC) — buy a 12–24 month call or outright equity exposure (target +25–40% upside if appropriations rise; downside -20% on program cancellation). Rationale: SLS boosters, missile-defense demand and classified sustained revenue; hedge with a 10–15% allocation in cash to cover a 6–12 month political shock.
• Long Lockheed Martin (LMT) vs short Virgin Galactic (SPCE) — pair trade equal notional. Timeframe 6–18 months. R/R: LMT capture of NASA/DoD backlog (20–30% upside under stable budgets) while SPCE faces commercial pricing pressure; pair limits macro beta while isolating program-specific flows.
• Long L3Harris (LHX) 12–18 month calls or stock — small-capitalization suppliers to ground-segment and avionics stand to benefit from sustained mission ops and LEO/Artemis comms work. Expected asymmetric payoff: 2:1 upside if NASA funds sustain, limited downside vs pure-play launchers.
• Event hedge: Buy cheap long-dated puts on small-cap launchers/space services (e.g., SPCE or other public pure-play leaf names) sized 1/3 of long-prime exposure. Protects portfolio from a rapid reallocation to commercial launch providers if Starship demonstrates reliable heavy-lift capability within 12–24 months.